insitro Advances AI-Discovered CTRO-1013 for MASH With Anti-Fibrotic Data
NEW ORLEANS, June 8, 2026 insitro announced new preclinical findings from its lead metabolic dysfunction-associated steatohepatitis (MASH) program, demonstrating...
artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology NSCLC Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
NEW ORLEANS, June 8, 2026 insitro announced new preclinical findings from its lead metabolic dysfunction-associated steatohepatitis (MASH) program, demonstrating...
SALT LAKE CITY, Utah, June 8, 2026 Seek Labs announced a major milestone in antiviral research with the completion...
SAN FRANCISCO, June 4 2026 Chai Discovery has announced a strategic license agreement with Pfizer that will enable the...
VALBY, Denmark and AMSTERDAM, Netherlands, June 3, 2026 Lundbeck and Cradle have announced a strategic partnership aimed at transforming...
CAMBRIDGE, Massachusetts, USA & PALO ALTO, California, USA, June 3, 2026 Alnylam Pharmaceuticals and Inceptive Nucleics have announced a...
WARSAW, Poland, June 3, 2026 Ingenix, an emerging artificial intelligence company focused on transforming drug discovery through advanced biological...
WALTHAM, Massachusetts, May 26, 2026 Mercy BioAnalytics, Inc. has announced that it will present new clinical data at the...
BOSTON, Massachusetts, May 26, 2026 Ginkgo Bioworks, through its Ginkgo Datapoints platform, has announced the launch of ADME-Oneâ„¢, a...
WILMINGTON, Del. & SAN MATEO, Calif., May 20, 2026 Incyte and Genesis Molecular AI have announced a significant expansion...
PORTLAND, Oregon, May 20, 2026 Araceli Biosciences announced the launch of Endeavor® Live Cell, a new ultra-high-throughput kinetic imaging...
